The Global PET Pharmaceutical Packaging market is estimated at $11.1 billion in 2014 with a CAGR of 11.3% it is expected to reach $26.2 billion by 2022. Rapid growth of pharmaceutical industry and growth in drug delivery devices are the key factors driving the market growth. Market access requirements such as supply-chain planning, manufacturing and distribution can be difficult. The regulatory environment, including taxation and import regimes, can be major barriers to growth, both in terms of working across borders. Challenges in emerging markets and increasing packaging costs are the factors hindering the market growth.
The opportunity lies in global demand for primary pharmaceutical containers. The quality control unit is responsible for the control of pharmaceutical packaging materials including their receipt, identification, sampling, testing, and approval or rejection of drug product containers and closures. Asia Pacific is estimated to be the leading market for PET Pharmaceutical Packaging due to rapid growth in the industrial use of PET in packaging and labelling applications being witnessed in this region.
Global Pharmaceutical Packaging market is segmented by type, by material and by geography. Based on type, market is segregated into bottles, jars, pouches & strip packs, medical specialty bags and others. Based on Material, market is divided into Paper & Paperboard, Aluminum Foil and Plastics/Polymers. Polyethylene Terephthalate (PET) pharmaceutical packaging market is segregated by type, by size and by material. Market by packaging type is segregated into Bottles, Jars and others. PET Plastic Bottle Packaging by size is divided into 5 ML, 50 ML and others. By material, market is segmented into special requirements and other market trends. Bottles segment is accounted to be the largest segment and Pouches & Strip Packs segment is having the highest market growth.
The Key players in the market include ITC Ltd., Bayer AG, Akzo Nobel NV, DuPont (EI) de Nemours, Evonik Industries AG, Sappi Ltd, Nippon Paper Group, Inc, Nalco Holding Company, International Paper Company and Mondi PLC.
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/pet-pharmaceutical-packaging-market-global-market-outlook-trends-forecast-and-opportunity-assessment-2014-2022
Table of content
1 Executive Summary
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources
3 Market Trend Analysis
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global pharmaceutical packaging market overview
5.1 Market by Packaging Type
5.1.3 Pouches & Strip Packs
5.1.4 Medical Specialty Bags
5.2 Market by Packaging Material
5.2.1 Paper & Paperboard
5.2.2 Aluminum Foil
6 Global Polyethylene Terephthalate (PET) pharmaceutical packaging market overview
6.1 Market by Packaging Type
6.2 PET Plastic Bottle Packaging Market By Size
6.2.1 5 ML
6.2.2 50 ML
6.3 Market by Packaging Material
6.3.1 Special Requirements
6.3.2 Other Market Trends
7 Market Trend Analysis
7.1 Glass bottles to PET bottles
7.2 Paper packaging to PET
7.3 Growth Opportunities or Revenue Pockets/Investment Opportunities
8 Global Pharmaceutical Packaging Market, By Geography
8.1 North America
8.3 Asia Pacific
8.4 Rest of the World
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.5 Other Key Strategies
10 Company Profiling
10.1 Clondalkin Group Holdings B.V.
10.2 NYPRO Inc.
10.3 Aptargroup, Inc.
10.4 Catalent Pharma Solutions Inc.
10.5 Intrapac Group
10.6 Amcor Ltd.
10.7 Datwyler Holding Inc.
10.8 CCL Industries Inc.
10.9 Capsugel Inc.
10.10 Gerresheimer AG
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
P: +44 208 133 9349
M: +1 646 845 9349